Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion for ADHD in adolescents with substance use disorder
NCT00936299Phase 4Completed
- Sponsor
- University of Colorado Denver
- Start
- Jan 2009
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupropion in attention deficit hyperactivity disorder (ADHD), nicotine dependence, cannabis use disorder (CUD), sponsored by University of Colorado Denver. Started Jan 2009; status: completed.
02
Drugs
bupropion
03
Conditions
attention deficit hyperactivity disorder (ADHD)nicotine dependencecannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT00936299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00936299.